What GMC concerns are most common for GPs, continuity of care, repeat prescribing, referral failures, remote consultation risks, and how GPs can demonstrate remediation
GPs face a distinct pattern of GMC fitness to practise concerns — shaped by the demands of high-volume primary care, the central role of the GP in continuity of patient care, and the increasing use of remote and telephone consultations. Understanding which concerns most commonly lead to GMC investigations in general practice helps GPs recognise risk earlier and respond more effectively.
General practice generates a distinctive profile of GMC concerns. GPs see a higher volume of patients than most secondary care colleagues, exercise greater clinical independence, and are responsible for the continuity of care over time in a way that most hospital specialists are not.
These features of general practice create specific risk patterns that differ from those in secondary care.
The most common categories of GMC concern for GPs include: delayed or missed diagnoses, prescribing concerns, failure to refer appropriately, inadequate management of chronic conditions, repeat prescribing without adequate review, and —
increasingly — complaints arising from remote and telephone consultations. These concerns often overlap — a delayed diagnosis may involve both a failure to examine adequately and a failure to refer at the appropriate time.
The clinical competence and patient safety framework that underpins GMC assessments applies fully in general practice.
Good Medical Practice requires GPs to maintain and develop their clinical knowledge and skills — and the RCGP's clinical standards provide the specific benchmark against which GP practice is assessed in GMC proceedings.
CPD Certified — Online — Immediate Access
Continuity of care is a defining feature of general practice — and a recurring source of GMC concerns. GPs are responsible for the longitudinal management of patients with chronic conditions. Failures in this longitudinal responsibility —
including failure to monitor and review ongoing treatment, failure to act on abnormal results, and failure to follow up missed appointments for high-risk patients — are common grounds for complaints.
Repeat prescribing without adequate clinical oversight is one of the most frequently identified concerns in GP GMC cases. The GMC expects GPs to have systems in place to ensure that repeat prescriptions are clinically justified,
that patients are reviewed at appropriate intervals, and that significant changes in clinical status are identified and acted upon. High-volume GP systems create pressure on these processes — but that pressure does not reduce the regulatory standard.
A comprehensive guide to GMC prescribing investigations covers the specific regulatory framework that applies to prescribing concerns in detail.
Referral failures and delayed diagnoses are a major source of GP GMC complaints — and often involve the most serious patient harms, including delayed cancer diagnoses. The GMC assesses whether the GP's clinical decision-making at each stage of the patient's journey met the standard expected of a reasonably competent GP in the same circumstances.
The two-week wait pathway and NICE cancer recognition guidelines provide important benchmarks. A GP who fails to use the two-week wait referral appropriately — or who fails to recognise symptoms that meet the NICE criteria for urgent referral — may be assessed against these specific guidelines in a GMC investigation.
Delayed diagnosis cases are particularly complex because hindsight can distort the assessment of what was clinically apparent at the time of the consultation. The GMC's expert witnesses and the MPTS tribunal assess the original consultation against the information available at that time — not against the final diagnosis.
Quality and Outcomes Framework data and clinical audit findings can identify patterns of practice that diverge from expected standards — and in some cases become the basis for GMC referrals, particularly through responsible officer referrals or CQC inspections that identify systemic clinical governance failures.
A GP whose practice consistently performs below expected QOF thresholds in high-risk clinical areas, or whose audit data shows patterns of care that fall below clinical guidelines, may face responsible officer scrutiny that escalates to GMC referral.
Understanding the clinical governance framework that applies to general practice is an important part of managing this risk.
The expansion of remote and telephone consultations — accelerated significantly during the pandemic — has created a new pattern of GP GMC complaints.
Remote consultations introduce specific clinical risks: the inability to examine the patient physically, challenges in assessing the severity of symptoms, and the risk that a patient's condition is more serious than can be assessed without in-person examination.
Good Medical Practice applies to remote consultations in the same way as face-to-face consultations. The GMC expects GPs to make a proper clinical assessment — including recognising when a remote consultation is not adequate and an in-person assessment is required.
A GP who conducts a telephone consultation for a patient presenting with symptoms that warranted in-person examination, and where patient harm results, faces the same standard of assessment as for any other clinical decision.
The consent and information provision requirements for remote consultations also require careful attention.
Remediation in a GP GMC case must address the specific concern raised. Generic ethics CPD is a starting point — not a complete response. For GP-specific concerns, the remediation evidence must include targeted engagement with the relevant clinical standards.
An effective GP remediation file includes: GP-specific CPD in the relevant clinical area — including RCGP resources and guidelines relevant to the concern; a reflective statement that specifically addresses the GP context of the concern and what has changed in clinical practice; evidence of engagement with clinical governance —
including significant event analysis, repeat prescribing audits, referral pattern audits, or QOF review; and supervisor or appraiser reports confirming that practice changes have been implemented.
The full framework for building an effective remediation file is set out in the guide to demonstrating remediation to the regulator.
UK-registered doctors can access professional ethics training through Healthcare Ethics Courses.
Doctors with connections to Australia can consult ethics training for Australian doctors.
Those with connections to New Zealand can review professional development for New Zealand doctors.
10 CPD-certified courses for £500. GP-relevant professional ethics, clinical governance, and patient safety — the CPD evidence that demonstrates genuine engagement with primary care standards.
Bulk Buy 10 Courses →Delayed or missed diagnoses, prescribing concerns, failure to refer appropriately, inadequate management of chronic conditions, repeat prescribing without adequate review, and complaints arising from remote and telephone consultations. These often overlap — a delayed diagnosis may involve both failure to examine adequately and failure to refer.
Yes. The GMC expects GPs to have systems ensuring repeat prescriptions are clinically justified, patients are reviewed at appropriate intervals, and significant clinical changes are acted upon. Failure to maintain these systems — particularly where patient harm results — is a clinical governance failure that can impair fitness to practise.
Against the standard of a reasonably competent GP in the same circumstances, at the time of the consultation, with the information then available. NICE cancer recognition guidelines and two-week wait criteria provide important benchmarks. The assessment is based on what was clinically apparent at the time — not on the eventual diagnosis.
Yes. QOF performance data, clinical audit findings, and CQC inspection reports can all form part of the evidence base in GMC proceedings — particularly in responsible officer referrals that identify patterns of care falling below expected standards.
The same clinical standards apply as for face-to-face consultations. GPs must make a proper clinical assessment remotely, recognise when in-person examination is required, and document their reasoning. A GP who manages a patient remotely when in-person assessment was warranted, and where harm results, faces the same standard of scrutiny as for any other clinical decision.
Yes. The RCGP's clinical standards and curriculum provide the specific benchmark against which GP practice is assessed in GMC proceedings involving clinical competence concerns. Engaging with RCGP resources and guidelines as part of a remediation response demonstrates knowledge of GP-specific standards.
A significant event analysis is a structured review of a clinical incident that identifies what happened, why, what was done, and what has changed. Completing an SEA in response to the concern underlying a GMC complaint demonstrates genuine engagement with clinical learning and improvement — and carries real evidential weight in remediation files.
Yes. Failure to refer a patient appropriately — particularly for red flag symptoms that should prompt urgent or two-week wait referral — is a common source of GP GMC complaints. The GMC's assessment focuses on whether the clinical decision met the standard of a reasonably competent GP at the time.
GP-specific CPD in the relevant clinical area, including RCGP resources. Professional ethics and Good Medical Practice CPD is essential context. Clinical governance CPD — including prescribing safety, referral processes, or remote consultation standards — should be tailored to the specific concern.
Yes. The GMC considers the full context of the doctor's practice — including workload, system pressures, staffing, and environmental factors. These are relevant to assessing whether the concern reflects individual failure or systemic issues. They do not excuse the conduct but are part of the overall picture.
In cases where a failure to conduct an adequate telephone consultation resulted in significant patient harm — particularly delayed diagnosis — serious sanctions including suspension are possible. The outcome depends on the severity of harm, the quality of the clinical decision-making, and the insight and remediation demonstrated.
An audit of the specific clinical area of concern — prescribing patterns, referral rates, chronic disease management — that demonstrates current practice meets the relevant standards. Where the original GMC concern identified a pattern of practice, an audit showing that pattern has changed provides independent documented evidence that practice has genuinely improved.
Yes. Contact your medical defence organisation (MDU, MPS, or MDDUS) immediately — even before a formal GMC letter arrives, if you are aware that a complaint has been made. Early advice helps you manage the process from the outset and avoids missteps that can be difficult to correct later.
This guide is for educational purposes only and does not constitute legal advice. If you are facing a GMC investigation, seek independent legal advice from a solicitor experienced in GMC regulatory proceedings.
